Kala Bio, Inc. (KALA): Capital Expenditures

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Capital Expenditures is for the year ended 2019-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$1.33M
Year ended 2019-12-31
+105.9%
3-year compound annual growth
$1.58M2015-12-31: $252.0K2016-12-31: $153.0K2017-12-31: $480.0K2018-12-31: $1.58M2019-12-31: $1.33M$1.33M
2015-12-31 Capital Expenditures (USD) 2019-12-31
Period endedCapital ExpendituresChange YoYSource filing
2019-12-31$1.33M-15.4%2020-02-12, From 2019-01-01
2018-12-31$1.58M+228.8%2020-02-12, From 2018-01-01
2017-12-31$480.0K+213.7%2019-03-12, From 2017-01-01
2016-12-31$153.0K-39.3%2018-04-02, From 2016-01-01
2015-12-31$252.0Kn/a2018-04-02, From 2015-01-01